Development of Secreted Protein and Acidic and Rich in Cysteine
(SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of
Metastatic Prostate Cancer

Awards Nomination 20+ Million Readerbase

Research Article - (2011) Volume 2, Issue 4

Stephanie Thomas¹, Peter Waterman³, Suelin Chen^2,⁴, Brett Marinelli³, Marc Seaman¹, Scott Rodig⁵, Robert W. Ross⁶, Lee Josephson², Ralph Weissleder^2,³ and Kimberly A. Kelly¹^*: ¹University of Virginia, Robert M. Berne Cardiovascular Research Center and the Biomedical Engineering Department, Charlottesville, Virginia, USA; ²Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA; ³Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA; ⁴Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; ⁵Department of Pathology, Brigham and Women’s Hospital, Boston Massachusetts, USA; ⁶Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston MA, USA

^*Corresponding Author: